ATC
KRYS icon

Argent Trust Co’s Krystal Biotech KRYS Stock Holding History

Argent Trust Co’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
1,426
+165
+13% +$49.3K 0.02% 491
2026
Q1 		$326K Hold
1,261
– – 0.01% 585
2025
Q4 		$311K Sell
1,261
-46
-4% -$9.68K 0.01% 584
2025
Q3 		$231K Buy
+1,307
New +$196K 0.01% 640
2025
Q2 		– Sell
-1,692
Closed -$305K – 718
2025
Q1 		$305K Sell
1,692
-207
-11% -$34.8K 0.01% 551
2024
Q4 		$297K Hold
1,899
– – 0.01% 556
2024
Q3 		$346K Buy
+1,899
New +$366K 0.01% 510

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Argent Trust Co's KRYS Position: Q2 2026 in Review

Argent Trust Co increased its Krystal Biotech (KRYS) stake by 13% in Q2 2026, buying an estimated $49.3K and bringing the position to 1,426 shares worth $530K. The position accounts for 0.02% of the portfolio, ranked #491.

Argent Trust Co first reported a position in KRYS in Q3 2024 and has held it in 7 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Argent Trust Co held 1,426 shares of Krystal Biotech worth $530K as of Q2 2026.
  • Argent Trust Co bought 165 Krystal Biotech shares in Q2 2026, an estimated $49.3K.
  • Krystal Biotech made up 0.02% of Argent Trust Co's portfolio in Q2 2026, its #491 holding.
  • Argent Trust Co first reported a position in Krystal Biotech in Q3 2024 and has held it in 7 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.